Methods and piperidinyl-alkyl-benzamide composition for inhibiting H2 histamine receptors

Pharmaceutical compositions for the treatment of ulcerative disorders comprising therapeutically effective amounts of compounds of the formula: ##STR1## wherein R is hydrogen, an alkyl group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, halo, amino, hydroxy, or where R is meta trifluoromethyl, n is 1, 2, or 3 when R is methoxy, but is otherwise 1, and x is 1, 2, or 3, with the proviso that when n is 1, R in the meta position is trifluoromethyl or hydrogen, and physiologically acceptable salts thereof.
Download pdf
Abstract/Description: Pharmaceutical compositions for the treatment of ulcerative disorders comprising therapeutically effective amounts of compounds of the formula: ##STR1## wherein R is hydrogen, an alkyl group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, halo, amino, hydroxy, or where R is meta trifluoromethyl, n is 1, 2, or 3 when R is methoxy, but is otherwise 1, and x is 1, 2, or 3, with the proviso that when n is 1, R in the meta position is trifluoromethyl or hydrogen, and physiologically acceptable salts thereof.
Subject(s): 514/331
Date Issued: 1982-01-12
Title: Methods and piperidinyl-alkyl-benzamide composition for inhibiting H2 histamine receptors.
Name(s): The University of Toledo, assignee
Roll, William D., inventor
Type of Resource: text
Genre: patent
Publisher: United States Patent and Trademark Office
Other Date: Date Filed: 1980-03-24
Date Issued: 1982-01-12
Physical Form: application/pdf
Extent: 4 p.
Abstract/Description: Pharmaceutical compositions for the treatment of ulcerative disorders comprising therapeutically effective amounts of compounds of the formula: ##STR1## wherein R is hydrogen, an alkyl group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, halo, amino, hydroxy, or where R is meta trifluoromethyl, n is 1, 2, or 3 when R is methoxy, but is otherwise 1, and x is 1, 2, or 3, with the proviso that when n is 1, R in the meta position is trifluoromethyl or hydrogen, and physiologically acceptable salts thereof.
Identifier(s): utpatents-US4310532 (IID)
Patent No.: US4310532 (patno)
Appl. No.: 06/133453 (appno)
Subject(s): 514/331
Held by: United States Patent and Trademark Office (USPTO) Public Search Facility
Location: University of Toledo Digital Repository
Rights Statement: No Copyright - United States
In Collections: